Harvey Capital Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Harvey Capital Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-14,675	Closed	-$2.94M	–	81
2015 Q4	$2.94M	Sell	14,675 -380	-3%	-$75.8K	1.16%	32
2015 Q3	$2.25M	Buy	15,055 +371	+3%	+$272K	0.9%	32
2015 Q2	$14.1M	Sell	14,684 -1,211	-8%	-$990K	4.76%	4
2015 Q1	$11.6M	Buy	15,895 +607	+4%	+$456K	4.28%	5
2014 Q4	$12.1M	Sell	15,288 -2,427	-14%	-$1.31M	4.65%	6
2014 Q3	$7.07M	Buy	17,715 +115	+0.7%	+$30.8K	2.77%	14
2014 Q2	$4.75M	Buy	17,600 +1,020	+6%	+$219K	1.7%	23
2014 Q1	$3.61M	Buy	16,580 +2,305	+16%	+$642K	1.44%	24
2013 Q4	$3.86M	Buy	14,275 +6,765	+90%	+$1.61M	1.59%	23
2013 Q3	$1.71M	Buy	+7,510	New	+$1.31M	0.87%	30

Other funds holding TTPH

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Harvey Capital Management's TTPH Position: Q1 2016 in Review

Harvey Capital Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q1 2016, closing a stake of 14,675 shares — an estimated $2.94M sold.

Harvey Capital Management first reported a position in TTPH in Q3 2013 and held it in 10 quarters. The position peaked at $14.1M in Q2 2015. 101 funds tracked by Wall St. Rank hold TTPH as of Q1 2016.

Harvey Capital Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q1 2016 after selling out during the quarter.
Harvey Capital Management sold 14,675 Tetraphase Pharmaceuticals, Inc. shares in Q1 2016, an estimated $2.94M.
Harvey Capital Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q3 2013 and held it in 10 quarters.
Harvey Capital Management's Tetraphase Pharmaceuticals, Inc. position peaked at $14.1M in Q2 2015.
101 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q1 2016.

Based on Harvey Capital Management's 13F filing for Q1 2016, filed 19 Apr 2016.